Researchers at Rochester Clinical Research are helping to test a new smallpox vaccine.
A drone delivery network will distribute medicines, vaccines, and blood, to 2,000 clinics in remote parts of Ghana.
Over the next four years, the experiences of these countries will help the WHO determine if RTS,S can be effectively used, and whether it will deliver the nearly 40 percent decrease in malaria infections seen in an earlier Phase 3 clinical trial.To see whether a new malaria vaccine, RTS, is effective, the World Health Organization (WHO) and partners have devised a limited rollout of the vaccine in Malawi followed by Ghana and Kenya.
At the University of Pennsylvania, researchers and clinicians have been aiming their energy and expertise at Ebola, searching in the lab for drugs to treat it, in the clinic for strategies to safely contain it, and in the field to understand the social and societal factors that bear on it.
The current study investigated the immunogenicity and protective response of rPA antigen formulated with the DPXTM no-release delivery platform (DPX-rPA). This unique formulation promotes a depot effect that attracts antigen-presenting cells to the vaccination site and elicits an immune response following single-dose delivery.
By developing a vaccine that targets specific cells in the immune system, researchers have seen a much greater immune and antibody response to the vaccine.
The US Biomedical Advanced Research and Development Authority (BARDA) has exercised another option under an ongoing contract for freeze-dried MVA-BN® smallpox vaccine.
A new study at the Tulane National Primate Research Center showed for the first time that an experimental drug can save nonhuman primates exposed to deadly ricin toxin.
Emergent BioSolutions NuThrax anthrax vaccine adsorbed with CPG 7909 Adjuvant is being studied for use as a third-generation anthrax vaccine.
Pirbright was designated as the world reference laboratory for foot-and-mouth disease (WRLFMD) by the Food and Agriculture Organization of the United Nations (FAO) in 1958. Over the past 60 years, the WRLFMD has played a leading role in coordinating international networks that improve laboratory diagnostic capacity and undertake global surveillance for FMD.